The Hanita CleaRing device is an intraocular implant designed for inhibition of PCO leading to reduction in the Nd:YAG treatment rate. The device is implanted into the capsular bag after the extraction of the crystalline lens and prior to implantation of the IOL. The device is manufactured by Hanita Lenses from a hydrophilic acrylic co-polymer which is being used for the production of Intra-ocular lenses.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
The first primary objective of this study is to evaluate the influence of Clearing open-capsule device on refractive predictability in cataract patients.
Timeframe: 1, 3 and 5 years
The second primary objective of this study is to evaluate the influence of Clearing open-capsule device on refractive predictability in cataract patients.
Timeframe: 1, 3 and 5 years
The third primary objective of this study is to evaluate the influence of Clearing open-capsule device on refractive predictability in cataract patients.
Timeframe: 1, 3 and 5 years